Obstacles to Improving Outcomes in the Treatment of Uveal Melanoma

Cancer - United States
doi 10.1002/cncr.31284
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Nanoparticles for Uveal Melanoma Treatment

2008English

Treatment of Uveal Melanoma: An Oncologist's View

Acta Ophthalmologica
MedicineOphthalmology
2018English

Does Ocular Treatment of Uveal Melanoma Influence Survival?

British Journal of Cancer
Cancer ResearchOncology
2010English

Prognosis in Uveal Melanoma

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1948English

Pembrolizumab as First-Line Treatment for Metastatic Uveal Melanoma

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2019English

Corrigendum to “Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience”

Case Reports in Oncological Medicine
Oncology
2019English

Immunoexpression of Macroh2a in Uveal Melanoma

Applied Sciences (Switzerland)
InstrumentationMaterials ScienceFluid FlowEngineeringComputer Science ApplicationsProcess ChemistryTransfer ProcessesTechnology
2019English

Telomerase Expression in Uveal Melanoma

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2000English

GermlineBAP1alterations in Familial Uveal Melanoma

Genes Chromosomes and Cancer
Cancer ResearchGenetics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy